Our research teams have made significant basic science contributions to the study of infectious disease-causing organisms and are paving the way for new therapies.
Yijun Sun, PhD, professor of microbiology and immunology, has received two large-scale R01 grants from the National Institutes of Health to study cancer evolution and progression.
The microbiology research community in Western New York and beyond gathered for the 33rd annual Buffalo Conference on Microbial Pathogenesis, hosted by the Witebsky Center for Microbial Pathogenesis and Immunology.
A University at Buffalo training program that aims to address the nation’s shortage of clinician-scientists has been recognized by the National Institutes of Health (NIH).
The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) has awarded six life sciences companies a total of $253,000 to support new biomedical technologies.
Prognostic analysis and progression modeling of basal-like breast cancer using multiregion sequencing. Yijun Sun (Principal Investigator). NIH. $3,159,483. 6/1/2023-6/1/2028.
Disease progression modeling of bladder cancer. Yijun Sun (Co-Principal Investigator). NIH. $2,507,223. 9/1/2022-8/1/2027.
Host and microbial risk factors of oral thrush in cancer patients receiving chemotherapy. Yijun Sun (Co-Investigator). NIH. $4,100,000. 7/1/2022-6/1/2027.